We are live on ! Find out more
Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $481B
1-Year Est. Return 30.42%
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+30.42%
3 Year Est. Return
+88.16%
5 Year Est. Return
+120.13%
10 Year Est. Return
+468.8%
AUM
$314B
AUM Growth
+$16.9B
Cap. Flow
+$2.33B
Cap. Flow %
0.74%
Top 10 Hldgs %
12.02%
Holding
3,572
New
111
Increased
1,840
Reduced
1,366
Closed
91

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$272M
2
CVX icon
Chevron
CVX
+$206M
3
TSLA icon
Tesla
TSLA
+$153M
4
NVDA icon
NVIDIA
NVDA
+$143M
5
PFE icon
Pfizer
PFE
+$131M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$242M
2
FSLR icon
First Solar
FSLR
+$153M
3
WMT icon
Walmart Inc
WMT
+$133M
4
STLD icon
Steel Dynamics
STLD
+$115M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$109M

Sector Composition

Rank Sector Weight
1 Technology 17.92%
2 Financials 15.55%
3 Industrials 13.68%
4 Consumer Discretionary 11.04%
5 Healthcare 10.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYT
3401
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$54.8K ﹤0.01%
+21,064
New +$44.1K
AMPG icon
3402
AmpliTech
AMPG
$124M
$53.8K ﹤0.01%
23,269
+9,582
+70% +$26.2K
ABEO icon
3403
Abeona Therapeutics
ABEO
$369M
$52.4K ﹤0.01%
12,991
TOON icon
3404
Kartoon Studios
TOON
$35.1M
$51.3K ﹤0.01%
26,694
-6,013
-18% -$15.9K
ELSE icon
3405
Electro-Sensors
ELSE
$27.3M
$51.2K ﹤0.01%
11,461
OPHC icon
3406
OptimumBank Holdings
OPHC
$86.5M
$50.8K ﹤0.01%
17,154
DTIL icon
3407
Precision BioSciences
DTIL
$181M
$50.2K ﹤0.01%
3,182
-8
-0.3% -$183
LGO
3408
Largo
LGO
$59.4M
$49.4K ﹤0.01%
11,580
-3,721
-24% -$16.6K
IDN icon
3409
Intellicheck
IDN
$74.5M
$48.8K ﹤0.01%
19,751
-8
-0% -$19
XLO icon
3410
Xilio Therapeutics
XLO
$59.7M
$46.8K ﹤0.01%
1,277
TCRT icon
3411
Alaunos Therapeutics
TCRT
$4.59M
$46.1K ﹤0.01%
603
-6
-1% -$485
CRDF icon
3412
Cardiff Oncology
CRDF
$66.2M
$46K ﹤0.01%
31,299
WIMI
3413
WiMi Hologram Cloud
WIMI
$22.2M
$45.5K ﹤0.01%
4,139
OXBR icon
3414
Oxbridge Re Holdings
OXBR
$10.6M
$44.9K ﹤0.01%
25,093
-16,276
-39% -$24K
TARA icon
3415
Protara Therapeutics
TARA
$227M
$44.8K ﹤0.01%
18,752
+1,918
+11% +$5.7K
PYXS icon
3416
Pyxis Oncology
PYXS
$182M
$44.8K ﹤0.01%
17,490
+5,403
+45% +$17.1K
LYEL icon
3417
Lyell Immunopharma
LYEL
$336M
$42.8K ﹤0.01%
673
-1,464
-69% -$81K
BBIG
3418
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$40.6K ﹤0.01%
+33,317
New +$102K
NXDR
3419
Nextdoor Holdings
NXDR
$858M
$38.6K ﹤0.01%
+11,832
New +$29.3K
BCEL
3420
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$38.2K ﹤0.01%
38,994
-47,803
-55% -$49.2K
SYRS
3421
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$37.8K ﹤0.01%
12,015
-18,211
-60% -$58.5K
VIOT
3422
Viomi Technology
VIOT
$50.9M
$36.9K ﹤0.01%
41,879
-96,323
-70% -$86.6K
SANW
3423
DELISTED
S&W Seed Co
SANW
$36.4K ﹤0.01%
1,571
AGIG
3424
Abundia Global Impact Group
AGIG
$41.4M
$36.4K ﹤0.01%
1,709
-829
-33% -$19.3K
BBGI icon
3425
Beasley Broadcasting Group
BBGI
$36.4M
$35.8K ﹤0.01%
1,756
-7,162
-80% -$138K

Similar funds

Dimensional Fund Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Dimensional Fund Advisors held 3,572 positions worth $314B, up 5.7% from $297B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Dimensional Fund Advisors's Q2 2023 filing shows 111 new, 1,840 increased, 1,366 reduced and 91 closed positions. Its largest new stake was Knife River: 1,268,239 shares worth $55.2M. The largest sale was Apple, an estimated $242M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.

  • Dimensional Fund Advisors's largest Q2 2023 buy was Knife River: 1,268,239 shares worth $55.2M.
  • Dimensional Fund Advisors added most to ExxonMobil in Q2 2023, an estimated $272M increase.
  • Dimensional Fund Advisors's biggest Q2 2023 reduction was Apple, cutting an estimated $242M.
  • Dimensional Fund Advisors fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $102M.
  • Dimensional Fund Advisors's ten largest holdings make up 12% of its $314B portfolio in Q2 2023.
  • Dimensional Fund Advisors opened 111 new positions and closed 91 in Q2 2023.
  • Dimensional Fund Advisors's portfolio value rose 5.7% quarter-over-quarter to $314B.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.